<DOC>
	<DOCNO>NCT00615420</DOCNO>
	<brief_summary>The primary hypothesis study regular topical oral application Manuka Honey reduce severity duration oral mucositis patient undergo mucotoxic radiation therapy cancer treatment .</brief_summary>
	<brief_title>A Randomized Placebo-Controlled Trial Manuka Honey Oral Mucositis Due Radiation Therapy Cancer</brief_title>
	<detailed_description>Oral mucositis common side-effect radiation therapy many head neck cancer , severe impact quality life nutritional status . At least42 % patient treat head neck cancer develop grade 3 4 oral mucositis . Although positive trial , study overwhelm data strongly support one agent prevention treatment oral mucositis . A comprehensive review literature do 2004 found benzydamine ( topical nonsteroidal anti-inflammatory agent ) beneficial palliative treatment establish mucositis . Management essentially consist pain management , topical oral analgesics/anaesthetics anti-inflammatory agent , nutritional support , mucositis establish . Despite use agent , many patient still severe mucositis , great need new treatment reduce distress complication cancer therapy . Currently , standard `` treatment '' consist oral rinse warm water , salt , bake soda 4 time day . This maintain oral hygiene impact severity duration mucositis . Topical fluoride apply bedtime reduce caries risk . Basic oral care ( brush floss tolerate ) recommend maintain general mucosal health reduce impact oral microbial flora . Study Objectives The primary objective study see topical oral Manuka honey reduces severity mucositis patient receive radiation treatment head neck cancer . Secondary objective assess impact demonstrate improvement mucositis nutrition , symptom burden , quality life , radiotherapy treatment interruption .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>Patients commence radiation therapy 50 Gy high dosage field affect oral mucosa unilaterally bilaterally ( minimum 3 observable site affect ) . Patients willing able attend weekly assessment throughout treatment , plus one week completion treatment . Patients unable understand consent process ( translator use necessary Englishspeaking require ) . Patients unable attend followup visit Patients participate clinical trial might affect severity mucositis Patients allergic honey , multiple pollen , celery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Mucositis</keyword>
	<keyword>Radiation</keyword>
	<keyword>Honey</keyword>
</DOC>